Australia, Aug. 15 -- Biohaven Therapeutics Ltd., owns the trademark (2519730) for 'REJUTRIA' till Nov. 22, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations and substances for the treatment of neurological, neuropsychiatric, neurodegenerative, viral, metabolic, obesity, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders.]
Type of Mark: Word
Date of Acceptance: April 23
Registration Advertised: Aug. 14
For further details contact Kessler Goldstein & Fox P.L.L.C Monica Riva Talley Sterne.
The original document can be viewed at: https...